Tecan, a global leader in laboratory automation and detection, has been granted Transcreener® Far Red FP validated status for its high-end multimode readers Infinite® M1000, Infinite F500 and Safire2™, by BellBrookLabs, LLC, a R&D-driven company and provider of enabling drug discovery screening tools for the pharmaceutical industry.

All of Tecan’s high-end multimode microplate readers outlined in this press release have shown outstanding performance and speed during the Transcreener® Far Red FP assay validation at BellBrookLabs, which tests the high quality fluorescence polarization detection capabilities of multimode microplate readers.

The Infinite M1000 is Tecan’s new, high-end, premium quad4 monochromators™-based multimode instrument, providing outstanding flexibility, sensitivity and speed for demanding applications in drug discovery, life sciences and research. Its new technology makes it the successor to Tecan’s high performance Safire2™ microplate reader.

The Infinite F500, Tecan’s high-end, filter-based multimode instrument, is Tecan’s most sensitive filter-based detection platform yet. It is based on the latest technological developments to provide a multifunctional and modular system that rapidly analyzes all your fluorescence- and luminescence-based assays at outstanding sensitivity levels.

About Tecan

Tecan (www.tecan.com) is a leading global supplier of laboratory instruments and solutions for the biopharma, forensic and diagnostic industries. The company specializes in the development, production and distribution of automation solutions for life science laboratories. Through its REMP subsidiary (www.remp.com), Tecan is the premier supplier of automated laboratory storage and logistics systems. Tecan's clients include pharmaceutical and biotech companies, university research departments, diagnostic laboratories and companies as well as forensics laboratories. Founded in Switzerland in 1980, the company has production, research and development sites in both North America and Europe and maintains a sales and service network in 52 countries. In 2007, Tecan achieved sales of CHF 414.4 million (USD 345.3 million; EUR 252.7 million). Registered shares of the Tecan Group are traded on the SWX Swiss Exchange (TK: TECN/Reuters: TECZn.S/Valor: 1210019).

For further information please contact:

Tecan Group Ltd.
Cornelia Kegele
Seestrasse 103
CH-8708 Männedorf

T +41 44 922 81 11
F +41 44 922 81 12
www.tecan.com

Transcreener is a registered trademark of BellBrookLabs, LLC, Madison, WI, USA.